nVerses Capital LLC Takes Position in Stevanato Group S.p.A. (NYSE:STVN)

nVerses Capital LLC purchased a new stake in shares of Stevanato Group S.p.A. (NYSE:STVN) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 4,200 shares of the company’s stock, valued at approximately $84,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the company. Hilltop National Bank raised its holdings in Stevanato Group by 34.3% in the 2nd quarter. Hilltop National Bank now owns 4,395 shares of the company’s stock valued at $81,000 after buying an additional 1,122 shares during the period. PNC Financial Services Group Inc. raised its holdings in Stevanato Group by 54.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 3,089 shares of the company’s stock valued at $84,000 after buying an additional 1,086 shares during the period. Harbor Capital Advisors Inc. raised its holdings in Stevanato Group by 109.1% in the 2nd quarter. Harbor Capital Advisors Inc. now owns 8,867 shares of the company’s stock valued at $163,000 after buying an additional 4,626 shares during the period. Raymond James Trust N.A. raised its holdings in Stevanato Group by 18.7% in the 2nd quarter. Raymond James Trust N.A. now owns 10,239 shares of the company’s stock valued at $188,000 after buying an additional 1,613 shares during the period. Finally, Oppenheimer Asset Management Inc. raised its holdings in Stevanato Group by 59.2% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 11,941 shares of the company’s stock valued at $219,000 after buying an additional 4,441 shares during the period.

Stevanato Group Stock Up 0.6 %

STVN stock opened at €18.32 ($19.91) on Monday. The company’s 50 day moving average price is €19.81 and its 200 day moving average price is €21.15. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.13 and a current ratio of 1.74. Stevanato Group S.p.A. has a fifty-two week low of €16.56 ($18.00) and a fifty-two week high of €34.73 ($37.75). The firm has a market capitalization of $5.41 billion, a price-to-earnings ratio of 33.31, a PEG ratio of 8.36 and a beta of 0.57.

Stevanato Group (NYSE:STVN) last released its earnings results on Tuesday, August 6th. The company reported €0.09 ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of €0.10 ($0.11) by (€0.01) (($0.01)). Stevanato Group had a return on equity of 10.89% and a net margin of 11.27%. The firm had revenue of €259.60 million for the quarter, compared to analysts’ expectations of €254.92 million. During the same quarter in the previous year, the company posted $0.15 earnings per share. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. On average, equities research analysts anticipate that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Citigroup reduced their price objective on shares of Stevanato Group from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Wednesday, August 7th. Morgan Stanley cut their price target on shares of Stevanato Group from $26.00 to $22.00 and set an “equal weight” rating on the stock in a research note on Monday, July 15th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of €29.25 ($31.79).

About Stevanato Group

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.